The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis
| Status: | Completed |
|---|---|
| Conditions: | Allergy, Asthma |
| Therapuetic Areas: | Otolaryngology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | January 2008 |
| End Date: | June 2011 |
This study will evaluate whether exhaled nitric oxide levels are affected by allergen
immunotherapy ("allergy shots"). The investigators' hypothesis is that successful allergen
immunotherapy may be accompanied by decreased exhaled nitric oxide levels.
immunotherapy ("allergy shots"). The investigators' hypothesis is that successful allergen
immunotherapy may be accompanied by decreased exhaled nitric oxide levels.
Inclusion Criteria:
- Subjects over 18 years old with allergic asthma and/or allergic rhinitis who are
beginning allergen desensitization
Exclusion Criteria:
- Smokers
- Subjects of dimished capacity
We found this trial at
1
site
Click here to add this to my saved trials
